Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-70
SponsorZhejiang University

About this trial

Pancreatic enucleation could preserve more healthy pancreatic tissues and functions with a low recurrence risk. However, conventional enucleation can cause significant intraoperative bleeding, especially in which tumors in the pancreatic head, neck, and uncinate process of pancreas, as these tissues are rich in blood supply, mainly including the abdominal trunk and the superior mesenteric artery. In this study, we developed a novel method to control the pancreatic blood flow in laparoscopic enucleation--blocking the abdominal trunk and superior mesenteric artery with vascular occlusion clips in the process of resection, and evaluated its effectiveness and safety.

Eligibility criteria

Qualifiers

Benign or borderline tumors diagnosed pathologically, such as pancreatic neuroendocrine tumors, solid pseudopapillary tumors, and cystadenomas, without vascular invasion or distant metastasis

Tumors sited in the pancreatic head, neck, and uncinate process of pancreas

Blockade of both the abdominal trunk and superior mesenteric artery in the laparoscopic enucleation

Disqualifiers

Highly malignant pancreatic tumors, or tumors with infiltration or metastasis

Tumors of the body and tail of the pancreas

Transfer to LPD or laparotomy

Trial design

Treatments tested in this trial

  • blocking both the abdominal trunk and superior mesenteric artery in the pancreatic enucleation

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators